By Siddhi Mahatole and Puyaan Singh (Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve ...

There are many different things that can cause memory problems that can mimic Alzheimer’s Disease, and appropriately ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with ...

Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...

The Alzheimer’s Foundation of America (AFA) is offering some tips for families to create a dementia-friendly Fourth of July.

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins at the critical interface between axons and their myelin sheath.

Shares of INmune Bio ( NASDAQ: INMB) dropped on Monday after the company did not achieve the main goal in a mid-stage trial ...

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease and other cognitive decline, and it goes a long way to explaining why there ...